Interaction of NO and VIP in gastrointestinal smooth muscle relaxation

Current Pharmaceutical Design

Volumn 10, Issue 20, 2004, Pages 2483-2497

  Van Geldre, L A ^a   Lefebvre, Romain A ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Gastrointestinal; Interaction; Nitric oxide; Postsynaptic; Presynaptic; Relaxation; Vasoactive intestinal polypeptide

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENYLATE CYCLASE; ANTISENSE OLIGONUCLEOTIDE; CARBACHOL; CYCLIC AMP; CYCLIC GMP; DEXAMETHASONE; FEDOTOZINE; GLUCOCORTICOID; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; KT 5823; LINSIDOMINE; METHACHOLINE; METHYLENE BLUE; MORPHINE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PROSTAGLANDIN F2 ALPHA; SEROTONIN; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST;

CELL ISOLATION; CELL VACUOLE; CELLULAR DISTRIBUTION; CHOLINERGIC NERVE CELL; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME INHIBITION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MUCOSA; HUMAN; IRRITABLE COLON; MYENTERIC PLEXUS; NERVE CONDUCTION; NERVE ENDING; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PATHOPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION;

ANIMALS; DRUG INTERACTIONS; GASTROINTESTINAL TRACT; HUMANS; MUSCLE RELAXATION; MUSCLE, SMOOTH; NEURAL PATHWAYS; NEURONS; NITRIC OXIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 3242885628     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043383890     Document Type: Review

References (163)

1. Furness JB, Bornstein JC, Kunze WAA, Clerc N. The enteric nervous system and its extrinsic connections. In: Yamada T Ed, Textbook of Gastroenterology. Philadelphia, Lippincot Williams and Wilkins 1999; 11-35.
2. Raybould HE, Pandol SJ. The integrated response of the gastrointestinal tract to a meal. In: Yamada T Ed, Textbook of Gastroenterology. Philadelphia, Lippincot Williams and Wilkins 1999; 2-10.
3. Shuttleworth CWR, Keef KD. Roles of peptides in enteric neuromuscular transmission. Reg Peptides 1995; 56: 101-20.
4. Burnstock G, Campbell G, Satchell DG, Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 1970; 40: 668-88.
5. Windscheif U, Pfaff O, Ziganshin AU, Hoyle CHV, Bäumert HG, Mutschler E, et al. Inhibitory action of PPADS on relaxant responses to adenine nucleotide or electrical field stimulation in guinea-pig taenia coli and rat duodenum. Br J Pharmacol 1995; 115: 1509-17.
6. + channels activated by ATP in murine colonic smooth muscle. Am J Physiol 1997; 42: C2010-21.
7. Kong ID, Koh SD, Sanders KM. Purinergic activation of spontaneous transient outward currents in guinea pig taenia colonic myocytes. Am J Physiol 2000; 278: C352-62.
8. Hökfelt T, Johansson O, Ljungdahl Å, Lundberg JM, Schultzberg M. Peptidergic neurones. Nature 1980; 284: 515-21.
9. Fahrenkrug J. VIP as a neurotransmitter in the peripheral nervous system. In: Said SI, ed. Vasoactive intestinal polypeptide. New York: Raven Press, 1982; 361-72.
10. Lefebvre RA. Study on the possible neurotransmitter of the non-adrenergic on-cholinergic innervation of the rat gastric fundus. Arch Int Pharmacodyn Ther 1986; 280: 110-36.
11. D'Amato M, Curro D, Ciabattoni G, Lefebvre RA. Is peptidine histidine isoleucine an inhibitory nonadrenergic noncholinergic neurotransmitter in the rat gastric fundus? Arch Int Pharmacodyn Ther 1990; 303: 216-31.
12. Lenard L Jr, Lazar Z, Benko R, Szigeti R, Bathori Z, Toth GK, et al. Inhibitory effect of PACAP (6-36) on relaxations induced by PACAP, VIP and non-adrenergic, non-cholinergic nerve stimulation in the guinea-pig taenia caeci. Naunyn Schmiedebergs Arch Pharmacol 2000; 361: 492-7.
13. Okishio Y, Niioka S, Takeuchi T, Nishio H, Hata F, Takatsuji K. Differences in mediator of nonadrenergic, noncholinergic relaxation of the distal colon between Wistar-ST and Sprague-Dawley strains of rats. Eur J Pharmacol 2000; 24: 97-105.
14. Okishio Y, Niioka S, Yamaji M, Yamazaki Y, Nishio H, Takeuchi T, et al. Mediators of nonadrenergic, noncholinergic relaxation in Sprague Dawley rat intestine: comparison with the mediators of other strains. J Vet Med Sci 2000; 62: 821-8.
15. Grider JR, Mahklouf GM. Prejunctional inhibition of vasoactive intestinal polypeptide release. Am J Physiol 1987; 253: G7-12.
16. De Beurme FA, Lefebvre RA. Vasoactive intestinal polypeptide as possible mediator of relaxation in the rat gastric fundus. J Pharm Pharmacol 1988; 40: 711-5.
17. D'Amato M, De Beurme FA, Lefebvre RA. Comparison of the effect of intestinal polypeptide and non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus. Eur J Pharmacol 1988; 152: 71-82.
18. Gillespie JS. Nonpurine, nonpeptide mechanisms. Arch Int Pharmacodyn 1990; 303: 20-9.
19. G-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. Br J Pharmacol 1989; 98: 1080-2.
20. Li CG, Rand MJ. Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin Exp Pharmacol Physiol 1989; 16: 933-8.
21. G-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br J Pharmacol 1990; 99: 602-6.
22. Bredt DS, Huang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768-70.
23. Boeckxstaens GE, Pelckmans TA, Ruytjens IF, Bult H, De Man JG, Herman AG, et al. Bioassay of nitric oxide released upon stimulation of nonadrenergic noncholinergic nerves in the canine ileocolonic junction. Br J Pharmacol 1991; 103: 1085-91.
24. Boeckxstaens GE, Pelckmans PA, Bogers JJ, Bult H, De Man JG, Oosterbosch L, et al. Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in the rat gastric fundus. J Pharmacol Exp Ther 1991; 256: 441-7.
25. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001; 96: 1422-8.
26. Berstad A, Hauksen T, Gilja OH, Hveem K, Undeland KA, Wilhelmsen I, et al. Gastric accommodation in functional dyspepsia. Scand J Gastroenterol 1997; 32: 193-7.
27. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterol 2001; 121: 526-35.
28. Quartero AO, De Wit NJ, Lodder AC, Numans ME, Smout AJ, Hoes AW. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998; 43: 2028-33.
29. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterol 1998; 115: 1346-52.
30. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut 1999; 45 (Suppl. 2): 37-42.
31. Boulant J, Mathieu S, D'Amato M, Abergel A, Dapoigny M, Bommelaer G. Cholecystokinin in transient lower esophageal sphincter relaxation due to gastric distension in humans. Gut 1997; 40: 575-81.
32. Kassim SK, El Touny M, El Guinaidy M, El Moghni MA, El Mohsen AA. Serum nitrates and vasoactive intestinal peptide in patients with gastroesophageal reflux disease. Clin Biochem 2002; 35: 641-6.
33. Schwartz D, Stollman N. University of Miami Division of Clinical Pharmacology therapeutic rounds: irritable bowel syndrome-pathophysiology, diagnosis, and treatment. Am J Ther 2000; 7: 265-72.
34. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 (Suppl. 2): 43-47.
35. Kellow JE, Delvaux M, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Priciples of applied neurogastroenterology: physiology/motility-sensation. Gut 1999; 45 (Suppl. 2): 17-24.
36. Ferzoco SJ, Modlin IM, Ballatyne GH. Counterregulation of a prokinetic calcium-dependent mechanism by cAMP-dependent agents in isolated segments of terminal ileum. J Surg Res 1993; 54: 107-14.
37. Franck H, Sweeney KM, Sanders KM, Shuttleworth CW. Effects of a novel guanylate cyclase inhibitor in canine proximal colon. Br J Pharmacol 1997; 122: 1223-9.
38. Mizuta Y, Takahashi T, Owyang C. Nitrergic regulation of colonic transit in rats. Am J Physiol 1999; 277: G275-9.
39. Fioramonti J, Bueno L. Centrally acting agents and visceral sensitivity. Gut 2002; 51 (Suppl. 1): i91-5.
40. Berezin I, Snyder SH, Bredt DS, Daniel EE. Ultrastructural localization of nitric oxide synthase in canine small intestine and colon. Am J Physiol 1994; 266: C981-9.
41. Allescher HD, Daniel EE, Dent J, Fox-Threlkeld JET. Inhibitory function of VIP/PHI and galanin in the canine pylorus. Am J Physiol 1989; 256: G789-97.
42. Grider JR, Cable MB, Said SI, Mahklouf GM. Vasoactive intestinal peptide as a neural mediator of gastric relaxation. Am J Physiol 1985; 248: G73-8.
43. Kobayashi R, Chen Y, Lee TD, Davis MT, Ito O, Walsh JH. Degradation of vasoactive intestinal polypeptide by rabbit gastric smooth muscle membranes. Peptides 1994; 15: 323-32.
44. Barnes K, Bourne A, Cook PA, Turner AJ, Kenny AJ. Membrane peptidases in the peripheral nervous system of the pig: their localization by immunohistochemistry at light and electron microscopic levels. Neuroscience 1991; 44: 245-61.
45. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, et al. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylated cyclase-activating polypeptide. Pharmacol Rev 1998; 50: 265-270.
46. Biancani P, Walsh JH, Behar J. Vasoactive intenstinal polypeptide: a neurotransmitter for relaxation of the rabbit internal anal sphincter. Gastroenterol 1985; 89 867-874.
47. De Beurme FA, Lefebvre RA. Influence of α-chymotrypsin and trypsin on the non-adrenergic non-cholinergic relaxation in the rat gastric fundus. Br J Pharmacol 1987; 91: 171-7.
48. Maggi CA, Giuliani S. Characterization of the apamin- and L-nitroarginine-resistent NANC transmission to the circular muscle of guinea-pig colon. J Auton Pharmacol 1996; 16: 131-45.
49. Usdin TB, Bonner TI, Mezey E. Tow receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinol 1994; 135: 2662-80.
50. Robberecht P, De Neef P, Lefebvre RA. Influence of selective VIP receptor agonists in the rat gastric fundus. Eur J Pharmacol 1998; 359: 77-80.
51. De Winter BY, Robberecht P, Boeckxstaens GE, De Man JG, Moreels TG, Herman AG, et al. Role of VIP/PACAP receptors in postoperative ileus in rats. Br J Pharmacol 1998; 124: 1181-6.
52. 1 receptor. Peptides 1997; 18: 1555-60.
53. Tams JW, Jorgensen RM, Holm A, Fahrenkrug J. Creation of a selective antagonist and agonist of the rat VPAC(I) receptor using a combinatorial approach with vasoactive intestinal peptide 6-23 as template. Mol Pharmacol 2000; 58: 1035-1041.
54. 2 receptor. Peptides 2000; 21: 1543-9.
55. Moody TW, Jensen RT, Fridkin M, Gozes I. (N-stearyl, norleucine17)VIPhybrid is a broad spectrum vasoactive intestinal peptide receptor antagonist. J Mol Neurosci 2002; 18: 29-35.
56. Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle. Phys Rev 1979; 59: 606-718.
57. Gozes I, Brenneman, DE. VIP: molecular and neurobiological function. Neurobiol 1989; 3: 201-36.
58. Murray KJ. Cyclic AMP and mechanisms of vasodilation. Pharmacol Ther 1990; 47: 329-345.
59. Wu G, Knabe DA, Flynn NE, Yan W, Flynn SP. Arginine degradation in developing porcine enterocytes. Am J Physiol 1996; 271: G913-9.
60. Hoffman RA, Zhang G, Nussler NC, Gleixner SL, Ford HR, Simmons RL, et al. Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol 1997; 272: G383-92.
61. MacNaughton WK, Lowe SS, Cushing K. Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis. Am J Physiol 1998; 275: G1353-60.
62. Schmidt HHHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochem Biophys Acta 1993; 1178: 153-75.
63. Stuehr DJ. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 1997; 37: 339-59.
64. Barbiers M, Timmermans J-P, Scheuermann DW, Adriaensen D, Mayer B, De Groodt-Lasseel MH. Nitric oxide synthase-containing neurons in the pig large intestine: topography, morphology, and viscerofugal projections. Microsc Res Tech 1994; 29: 72-8.
65. Singaram C, Sengupta A, Sweet MA, Surgarbaker DJ, Goyal RK. Nitrinergic and peptidergic innervation of the human oesophagus. Gut 1994; 35: 1690-6.
66. Ward SM, Xue C, Sanders KM. Localization of nitric oxide synthase in canine ileocolonic and pyloric sphincters. Cell Tissue Res 1994; 275: 513-27.
67. 2+ dependency of the release of nitric oxide from non-adrenergic non-cholinergic nerves. Br J Pharmacol 1993; 110: 1329-34.
68. 2+ channels coupled to VIP release and NO synthesis in enteric synaptosomes. Am J Physiol 2002; 283: G1027-34.
69. Iversen HH, Wiklund NP, Gustafson LE. Nitric oxide-like activity in guinea pig colon as determined by effector responses, bioassay and chemiluminescence analysis. Acta Physiol Scand 1994; 152: 315-22.
70. Hata F, Ishii T, Kanada A, Yamano N, Kataoka T, Takeuchi T, et al. Essential role of nitric oxide in descending inhibition in the rat proximal colon. Biochem Biophys Res Commun 1990; 172: 1400-6.
71. Toda N, Baba H, Okamura T. Role of nitric oxide in non-adrenergic, non-cholinergic nerve-mediated relaxation in dog duodenal longitudinal muscle strips. Japan J Pharmacol 1990; 53: 281-4.
72. O'Kelly T, Brading A, Mortensen N. Nerve mediated relaxation of the human internal anal sphincter: the role of nitric oxide. Gut 1993; 34: 689-693.
73. Sanders KM, Ward SM. Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am J Physiol 1992; 262: G379-92.
74. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one. Mol Pharmacol 1995; 48: 184-8.
75. Lefebvre RA. Influence of a selective guanylate cyclase inhibitor, and of the contraction level, on nitrergic relaxations in the rat gastric fundus. Br J Pharmacol 1998; 124: 1439-48.
76. Shahin W, Murray JA, Clark E, Conklin JL. Role of cGMP as a mediator of nerve-induced motor functions of the opossum esophagus. Am J Physiol 2000; 279: G567-74.
77. Zyromski NJ, Duenes JA, Kendrick ML, Balsiger BM, Farrugia G, Sarr MG. Mechanism mediating nitric oxide-induced inhibition in human jejunal longitudinal smooth muscle. Surgery 2001; 130: 489-96.
78. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature Lond 1990; 345: 346-7.
79. Baker RA, Saccone GTP, Brookes SJH, Toouli J. Nitric oxide mediates nonadrenergic, noncholinergic neural relaxation in the Australian opossum. Gastroenterol 1993; 105: 1746-1753.
80. Martin W, McAllister KHM, Paisley K. NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of superoxide dismutase with diethyldithiocarbamate. Neuropharmacol 1999; 33: 1293-1301.
81. La M, Rand MJ. Effects of pyrogallol, hydroquinone and duroquinone on responses to nitrergic nerve stimulation and NO in rat anococcygeus muscle. Br J Pharmacol 1999; 126: 342-8.
82. Barbier AJM, Lefebvre RA. Effect of LY 83583 on relaxation induced by non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundus. Eur J Pharmacol 1992; 219: 331-4.
83. Gibson A, Brave S, McFadzean I, Wayman CP. The nitrergic transmitter of the anococcygeus - NO or not? Arch Int Pharmacodyn Ther 1995; 329: 39-51.
84. Rand MJ, Li CG. Discrimination by the NO-trapping agent carboxy-PTIO, between NO and the nitrergic transmitter but not between NO and EDRF. Br J Pharmacol 1995; 116: 1906-10.
85. Martin W, McAllister KMH, Paisley K. NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of superoxide dismutase with diethyldithiocarbamate. Neuropharmacol 1994; 33: 1293-1301.
86. Colpaert EE, Lefebvre RA. Influence of bilirubin and other antioxidants on nitrergic relaxation in the pig gastric fundus. Br J Pharmacol 2000; 129: 1201-11.
87. Colpaert EE, Timmermans J-P, Lefebvre RA. Influence of antioxidant depletion on nitrergic relaxation in the pig gastric fundus. Br J Pharmacol 2002; 135: 917-926.
88. Denninger JW, Marletta MA. Guanylate cyclase and the NO/cGMP signaling pathway. Biochem Biophys Acta 1999; 1411: 334-50.
89. Pfeifer A, Klatt P, Massberger S, Ny L, Sausbier M, Hirnheiß C, et al. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 1998; 17: 3045-51.
90. Ny L, Pfeifer A, Aszodi A, Ahmad M, Alm P, Hedlund P, et al. Impaired relaxation of stomach smooth muscle in mice lacking cyclin GMP-dependent protein kinase I. Br J Pharmacol 2000; 129: 395-401.
91. 2+-ATPase in the smooth muscle tone or the cat gastric fundus. Eur J Pharmacol 1996; 431: 928-35.
92. Lincoln TM, Komalavilas P. Cyclic GMP-mediated signaling mechanisms in smooth muscle. In: Ed, Nitric Oxide, New York, Academic Press, 2000; 401-25.
93. Ekblad E, Mulder H, Uddman R, Sundler F. NOS-containing neurons in rat gut and coeliac ganglia. Neuropharmacol 1994; 33: 1323-31.
94. Timmermans J-P, Barbiers M, Scheuermann DW, Stach W, Adriaensen D, Mayer B, et al. Distribution pattern, neurochemical features and projections of nitrergic neurons in the pig small intestine. Anat Anz 1994; 176: 515-25.
95. 2+-independent nitric oxide synthases. FEBS Lett 1991; 291: 145-9.
96. Mule F, Vannucchi MG, Corsani L, Serio R, Faussone-Pellegrini MS. Myogenic NOS and endogenous NO production are defective in colon from dystrophic (mdx) mice. Am J Physiol 2001; 281: G1264-70.
97. Schemann M, Schaaf C, Mader M. Neurochemical coding of enteric neurons in the guinea pig stomach. J Comp Neurol 1995; 353: 161-78.
98. Sann H, Hopp S, Baldwin L, Grundy D, Shemann M. Presence of putative neurotransmitters in the myenteric plexus of the gastrointestinal tract and in the musculature of the urinary bladder of the ferret. Neurogastroenterol Motil 1998; 10: 35-47.
99. Pfannkuche H, Schemann M, Gabel G. Ruminal muscle of sheep is innervated by non-polarized pathways of cholinergic and nitrergic myenteric neurons. Cell Tissue Res 2002; 309: 37-54.
100. Simula ME, Brookes SJ, Meedeniya AC, Toouli J, Saccone GT. Distribution of nitric oxide synthase and vasoactive intestinal polypeptide immunoreactivity in the sphincter of Oddi and duodenum of the possum. Cell Tissue Res 2001; 304: 31-41.
101. Mann PT, Furness JB, Southwell BR. Choline acetyltransferase immunoreactivity of putative intrinsic primary afferent neurons in the rat ileum. Cell Tissue Res 1999; 297: 241-8.
102. Porter AJ, Wattchow DA, Brookes SJ, Costa M. The neurochemical coding and projections of circular muscle motor neurons in the human colon. Gastroenterol 1997; 113: 1916-23.
103. Song ZM, Brookes SJ, Gibbins IL, Costa M. NADPH-diaphorase and other neuronal markers in nerves and ganglia supplying the guinea-pig vas deferens. J Auton Nerv Syst 1994; 48: 31-43.
104. Reuss S, Decker K, Rosseler L, Layes E, Schollmayer A, Spessert R. Nitric oxide synthase in the hypothalamic suprachiasmatic nucleus of the rat: evidence from histochemistry, immunohistochemistry and western blot; and colocalization with VIP. Brain Res 1995; 695: 257-62.
105. He XD, Goyal RK. Nitric oxide involvement in the peptide VIP-associated inhibitory junction potential in the guinea-pig ileum. J Physiol 1993; 461: 485-99.
106. Chakder S, Rattan S. Evidence for VIP-induced increase in NO production in myenteric neurons of opossum internal anal sphincter. Am J Physiol 1996; 270: G492-7.
107. Huizinga JD, Tomlinson J, Pintin-Quezada J. Involvement of nitric oxide in nerve-mediated inhibition and action of vasoactive intestinal polypeptide in colonic smooth muscle. J Pharm Exp Ther 1992; 260: 803-8.
108. Mashimo H, He XD, Huang PL, Fishman MC, Goyal RK. Neuronal constitutive nitric oxide synthase is involved in murine enteric inhibitory neurotransmission. J Clin Invest 1996; 98: 8-13.
109. Csillag A, Hajos F, Zilles K, Schleicher A, Schroder H. Matching localization of vasoactive intestinal polypeptide (VIP) and VIP-receptor at pre- and postsynaptic sites in the mouse visual cortex. J Neurocytol 1993; 22: 491-7.
110. Wang HL, Li A, Wu T. Vasoactive intestinal polypeptide enhances the GABAergic synaptic transmission in cultured hippocampal neurons. Brain Res 1997; 746: 294-300.
111. Mao YK, Wang YF, Daniel EE. Distribution and characterization of vasoactive intestinal polypeptide binding in canine lower esophageal sphincter. Gastroenterol 1993; 105: 1370-7.
112. Ekblad E. Pharmacological evidence for both neuronal and smooth muscle PAC1 receptors and a VIP-specific receptor in rat colon. Regul Pept 1999; 85: 87-92.
113. Grider JR, Murthy KS, Jin, JG, Makhlouf GM. Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release. Am J Physiol 1992; 262: G774-8.
114. Daniel EE, Haugh C, Woskowska Z, Cipris S, Jury J, Fox-Threlkeld JE. Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide. Am J Physiol 1994; 266: G31-9.
115. Jin JG, Murthy KS, Grider JR, Makhlouf GM. Stoichiometry of neurally induced VIP release, NO formation, and relaxation in rabbit and rat gastric muscle. Am J Physiol 1996; 271: G357-69.
116. Chakder S, Rattan S. Involvement of pituitary adenylate cyclase-activating peptide in opossum internal anal sphincter relaxation. Am J Physiol 1998; 275: G769-77.
117. Grider JR, Jin JG. Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myenteric plexus: evidence for regulation of vasoactive intestinal peptide release by nitric oxide. Neuroscience 1993; 54: 521-6.
118. Allescher HD, Kurjak M, Huber A, Trudrung P, Schusdziarra V. Regulation of VIP release from rat enteric nerve terminal for a stimulatory effect of NO. Am J Physiol 1996; 271: G568-74.
119. Kurjak M, Fritsch R, Saur D, Schusdziarra V, Allescher HD. Functional coupling between nitric oxide synthesis and VIP release within enteric nerve terminals of the rat: involvement of protein kinase G and phosphodiesterase 5. J Physiol 2001; 534: 827-36.
120. Matsuyama H, Unno T, El-Mahmoudy AM, Komori S, Kobayashi H, Thapaliya S, et al. Peptidergic and nitrergic inhibitory neurotransmissions in the hamster jejunum: regulation of vasoactive intestinal peptide release by nitric oxide. Neuroscience 2002; 110: 779-88.
121. 2+ influx activates a constitutive NOS in dispersed gastric muscle cells. Am J Physiol 1993; 265: G660-71.
122. Grider JR. Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. Am J Physiol 1993; 264: G334-40.
123. Jin JG, Murthy KS, Grider JR, Makhlouf GM. Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Am J Physiol 1993; 264: G470-7.
124. Murthy KS, Makhlouf GM. Interaction of cA-kinase and cG-kinase in mediating relaxation of dispersed smooth muscle cells. Am J Physiol 1995; 268: G171-80.
125. Murthy KS, Teng B, Jin J, Makhlouf GM. G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor. Am J Physiol 1998; 275: C1409-16.
126. Teng B-Q, Murthy KS, Kuemmerle JF, Grider JR, Sase K, Michel T, et al. Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. Am J Physiol 1998; 275: G342-51.
127. Daniel EE, Jury J, Salapatek AM, Bowes T, Lam A, Thomas S, et al. Nitric oxide from enteric nerves acts by a different mechanism from myogenic nitric oxide in canine lower esophageal sphincter. J Pharmacol Exp Ther 2000; 294: 270-9.
128. Salapatek AMF, Wang Y-F, Mao Y-K, Lam, A, Daniel EE. Myogenic nitric oxide synthase activity in canine lower oesophageal sphincter: morphological and functional evidence. Br J Pharmacol 1998; 123: 1055-64.
129. Salapatek AMF, Wang Y-F, Mao Y-K, Mori M, Daniel EE. Myogenic NOS in canine lower esophageal sphincter: enzyme activation, substrate recycling, and product actions. Am J Physiol 1998; 274: C1145-57.
130. Boeckxstaens GE, Pelckmans PA, De Man JG, Bult H, Herman AG, Van Maercke YM. Evidence for a differential release of nitric oxide and vasoactive intestinal polypeptide by nonadrenergic noncholinergic nerves in the rat gastric fundus. Arch Int Pharmacodyn Ther 1992; 318: 107-15.
131. Barbier AJ, Lefebvre RA. Involvement of the L-arginine: nitric oxide pathway in nonadrenergic noncholinergic relaxation of the cat gastric fundus. J Pharmacol Exp Ther 1993; 266: 172-8.
132. Bartfai K, Iverfeldt K, Fisone G. Regulation of the release of coexisting neurotransmitters. Annu Rev Pharmacol Toxicol 1988; 28: 285-310.
133. Li CG, Rand MJ. Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur J Pharmacol 1990; 191: 303-9.
134. Tonini M, De Giorgio R, De Ponti F, Sternini C, Spelta V, Dionigi P, et al. Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations. Br J Pharmacol 2000; 129: 12-20.
135. Grundy D, Gharib-Naseri MK, Hutson D. Role of nitric oxide and vasoactive intestinal polypeptide in vagally mediated relaxation of the gastric corpus in the anaesthetized ferret. J Auton Nerv Syst 1993; 43: 241-6.
136. Tøttrup A, Svane D, Forman A. Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter. Am J Physiol 1991; 260: G385-9.
137. De Man JG, Pelckmans PA, Boeckxstaens GE, Bult H, Oosterbosch L, Herman AG, et al. The role of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine oesophageal sphincter. Br J Pharmacol 1991; 103: 1092-6.
138. Tøttrup A, Ny L, Alm P, Larsson B, Forman A, Andersson KE. The role of the L-arginine/nitric oxide pathway for relaxation of the human lower oesophageal sphincter. Acta Physiol Scand 1993; 149: 451-9.
139. Kortezova N, Mizhorkova Z, Milusheva E, Varga G, Vizi ES, Papasova M. Non-adrenergic non-cholinergic neuron stimulation in the cat lower esophagheal sphincter. Eur J Pharmacol 1996; 304: 109-15.
140. Lefebvre RA, Smits GJ, Timmermans JP. Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus. Br J Pharmacol 1995; 116: 2017-26.
141. Ergün Y, Ögülener N, Dikmen A. Involvement of nitric oxide in non-adrenergic non-cholinergic relaxation and action of vasoactive intestinal polypeptide in circular muscle strips of the rat gastric fundus. Pharmacol Res 2001; 44: 221-8.
142. Dick JM, Van Molle W, Brouckaert P, Lefebvre RA. Relaxation by vasoactive intestinal polypeptide in the gastric fundus of nitric oxide synthase-deficient mice. J Physiol 2002; 538: 133-43.
143. Lefebvre RA, Baert E, Barbier AJ. Influence of NG-nitro-L-arginine on non-adrenergic non-cholinergic relaxation in guinea-pig gastric fundus. Br J Pharmacol 1992; 106: 173-9.
144. Dick JMC, Van Geldre LA, Timmermans J-P, Lefebvre RA. Investigation of the interaction between nitric oxide and vasoactive intestinal polypeptide in the guinea-pig gastric fundus. Br J Pharmacol 2000; 129: 751-63.
145. Bayguinov O, Keef KD, Hagen B, Sanders KM. Parallel pathways mediated inhibitory effects of vasoactive intestinal polypeptide and nitric oxide in canine fundus. Br J Pharmacol 1999; 126: 1543-52.
146. Dick JM, Lefebvre RA. Interplay between nitric oxide and vasoactive intestinal polypeptide in the pig gastric fundus smooth muscle. Eur J Pharmacol 2000; 397: 389-97.
147. Ekblad E, Sundler, F. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle. Eur J Pharmacol 1997; 334: 61-6.
148. Martin MT, Gonalons E, Fernandez E. Contribution of inhibitory neurotransmitters to the CCK induced relaxation of the circular muscle of avian ileum. Life Sci 1998; 62: 937-46.
149. Matsumada NM, Feitosa RL Jr, Lemos MC, De Oliveira RB, Ballejo G. In vitro and in vivo effects of nitric oxide synthase inhibitors and nitric oxide inactivators on the South American opossum ileocolonic junction. Neurogastroenterol Motil 1998; 10: 245-52.
150. Briejer MR, Akkermans LM, Meulemans AL, Lefebvre RA, Schuurkens JA. 5-HT -induced relaxations of the guinea-pig proximal colon: investigation into the role of ATP and VIP in addition to nitric oxide. Naunyn Schmiedebergs Arch Pharmacol 1995; 351: 126-35.
151. McLaren A, Li CG, Rand MJ. Mediators of nicotine-induced relaxations of the rat gastric fundus. Clin Exp Pharmacol Physiol 1993; 20: 451-7.
152. Murthy KS, Jin JG, Makhlouf GM. Inhibition of nitric oxide synthase activity in dispersed gastric muscle cells by protein kinase C. Am J Physiol 1994; 266: G161-65.
153. Rattan S, Chakder S. Role of nitric oxide as a mediator of internal anal sphincter relaxation. Am J Physiol 1992; 262: G107-12.
154. Ergün Y, Ögülener N. Evidence for the interaction between nitric oxide and vasoactive intestinal polypeptide in the mouse gastric fundus. J Pharmacol Exp Ther 2001; 299: 945-50.
155. Baccari MC, Iacoviello C, Calamai F. Nitric oxide as modulator of cholinergic neurotransmission in gastric muscle of rabbit. Am J Physiol 1997; 273: G456-63.
156. Rekik M, Delvaux M, Tack I, Frexinos J, Bueno L. VIP-induced relaxation of guinea-pig intestinal smooth muscle cells: sequential involvement of cyclic AMP and nitric oxide. Br J Pharmacol 1996; 118: 477-84.
157. Di Rosa RM. Radomski M, Carnuccio R, Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 1990; 172: 1246-52.
158. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-7.
159. Walker G, Pfeilschifter J, Kunz D. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in interferon (IFN)-γ-stimulated RAW 264.7 cells by dexamethasone. J Biol Chem 1996; 271: 16679-16687.
160. Dick JMC, Van Molle W, Libert C, Lefebvre RA. Antisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundus. Br J Pharmacol 2001; 134: 425-33.
161. Burgaud JL, Riffaud JP, Del Soldato P. Nitric-oxide releasing molecules: a new class of drugs with several major indications. Curr Pharm Design 2002; 8(3): 201-13.
162. Gozes I, Furman S. VIP and drug design. Curr Pharm Design 2003; 9(6): 483-94.
163. Skelly MM, Hawkey CJ. Dual COX inhibition and upper gastrointestinal damage. Curr Pharm Design 2003; 9(27): 2191-5.